CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | Shah Pritesh Chief Growth Officer | Grant or award | +19,055 | 101,898 | ||
| 2023-02-28 | Shah Pritesh Chief Growth Officer | Grant or award · Options to Buy Ordinary Shares | +31,691 | $76.97 | $2.4M | 31,691 |
| 2023-02-28 | Weinberg Uri Chief Innovation Officer | Grant or award | +12,992 | 56,278 | ||
| 2023-02-28 | Weinberg Uri Chief Innovation Officer | Grant or award · Options to Buy Ordinary Shares | +21,607 | $76.97 | $1.7M | 21,607 |
| 2023-02-28 | Ben Arye Barak General Counsel | Grant or award | +17,755 | 34,907 | ||
| 2023-02-28 | Ben Arye Barak General Counsel | Grant or award · Ordinary Shares | +29,531 | $76.97 | $2.3M | 29,531 |
| 2023-02-28 | Cordova Ashley Chief Financial Officer | Grant or award | +23,818 | 98,260 | ||
| 2023-02-28 | Cordova Ashley Chief Financial Officer | Grant or award · Options to Buy Ordinary Shares | +39,614 | $76.97 | $3.0M | 39,614 |
| 2023-02-28 | Burke William Patrick Chief Human Resources Officer | Grant or award | +12,125 | 67,719 | ||
| 2023-02-28 | Burke William Patrick Chief Human Resources Officer | Grant or award · Options to Buy Ordinary Shares | +20,168 | $76.97 | $1.6M | 20,168 |
| 2023-02-28 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +21,653 | 186,779 | ||
| 2023-02-28 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award · Options to Buy Ordinary Shares | +36,013 | $76.97 | $2.8M | 36,013 |
| 2023-01-06 | Ben Arye Barak General Counsel | Grant or award | +150 | $62.31 | $9K | 17,152 |
| 2023-01-06 | Cordova Ashley Chief Financial Officer | Grant or award | +66 | $62.31 | $4K | 74,442 |
| 2023-01-06 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +102 | $62.31 | $6K | 165,126 |
| 2023-01-06 | Benaim Ely Chief Medical Officer | Grant or award | +98 | $62.31 | $6K | 28,770 |
| 2023-01-06 | Burke William Patrick Chief Human Resources Officer | Grant or award | +108 | $62.31 | $7K | 55,594 |
| 2023-01-06 | Danziger Asaf Chief Executive Officer | Grant or award | +39 | $62.31 | $2K | 13,622 |
| 2023-01-05 | Weinberg Uri Chief Science Officer | Sale | −2,379 | $120.00 | $285K | 47,104 |
| 2023-01-05 | Weinberg Uri Chief Science Officer | Exercise or conversion | +1,946 | $47.04 | $92K | 49,050 |
Page 16 of 20 · 399 trades